1. Home
  2. GKOS vs EXLS Comparison

GKOS vs EXLS Comparison

Compare GKOS & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • EXLS
  • Stock Information
  • Founded
  • GKOS 1998
  • EXLS 1999
  • Country
  • GKOS United States
  • EXLS United States
  • Employees
  • GKOS N/A
  • EXLS 59500
  • Industry
  • GKOS Medical/Dental Instruments
  • EXLS Business Services
  • Sector
  • GKOS Health Care
  • EXLS Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • EXLS Nasdaq
  • Market Cap
  • GKOS 5.8B
  • EXLS 6.9B
  • IPO Year
  • GKOS 2015
  • EXLS 2006
  • Fundamental
  • Price
  • GKOS $89.83
  • EXLS $42.34
  • Analyst Decision
  • GKOS Strong Buy
  • EXLS Strong Buy
  • Analyst Count
  • GKOS 12
  • EXLS 6
  • Target Price
  • GKOS $131.17
  • EXLS $51.50
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • EXLS 1.8M
  • Earning Date
  • GKOS 07-30-2025
  • EXLS 07-29-2025
  • Dividend Yield
  • GKOS N/A
  • EXLS N/A
  • EPS Growth
  • GKOS N/A
  • EXLS 34.45
  • EPS
  • GKOS N/A
  • EXLS 1.45
  • Revenue
  • GKOS $432,953,000.00
  • EXLS $1,968,978,000.00
  • Revenue This Year
  • GKOS $27.88
  • EXLS $14.23
  • Revenue Next Year
  • GKOS $27.76
  • EXLS $11.43
  • P/E Ratio
  • GKOS N/A
  • EXLS $29.18
  • Revenue Growth
  • GKOS 26.70
  • EXLS 15.15
  • 52 Week Low
  • GKOS $77.10
  • EXLS $35.00
  • 52 Week High
  • GKOS $163.71
  • EXLS $52.43
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • EXLS 45.19
  • Support Level
  • GKOS $88.94
  • EXLS $41.93
  • Resistance Level
  • GKOS $92.70
  • EXLS $43.24
  • Average True Range (ATR)
  • GKOS 3.82
  • EXLS 1.10
  • MACD
  • GKOS 0.38
  • EXLS 0.12
  • Stochastic Oscillator
  • GKOS 46.71
  • EXLS 8.45

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: